• LAST PRICE
    36.2100
  • TODAY'S CHANGE (%)
    Trending Up0.6200 (1.7421%)
  • Bid / Lots
    36.1400/ 2
  • Ask / Lots
    36.2900/ 3
  • Open / Previous Close
    35.0600 / 35.5900
  • Day Range
    Low 35.0012
    High 36.3600
  • 52 Week Range
    Low 10.7000
    High 78.0000
  • Volume
    240,246
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 35.59
TimeVolumeVERV
09:32 ET616935.0012
09:34 ET85035.96
09:36 ET70035.575
09:38 ET20035.77
09:39 ET120035.47
09:41 ET49435.55
09:43 ET149535.67
09:45 ET30035.51
09:48 ET264135.61
09:50 ET95535.54
09:52 ET180035.54
09:54 ET458035.12
09:56 ET301935.45
09:57 ET286035.485
09:59 ET121635.5
10:01 ET1177035.37
10:03 ET140035.68
10:06 ET370035.855
10:08 ET279935.54
10:10 ET146635.71
10:12 ET20035.615
10:14 ET10035.6
10:15 ET330035.45
10:17 ET540735.39
10:19 ET300035.395
10:21 ET390035.45
10:24 ET120035.51
10:26 ET314935.41
10:28 ET140535.45
10:30 ET160035.64
10:32 ET110035.685
10:33 ET165135.85
10:35 ET402536.07
10:37 ET60036.135
10:39 ET264636.06
10:42 ET99236
10:44 ET110036.12
10:46 ET90036
10:48 ET143636.01
10:50 ET376335.58
10:51 ET260035.7
10:53 ET150035.565
10:55 ET40035.645
10:57 ET50135.65
11:00 ET164435.5
11:02 ET170035.385
11:04 ET154035.46
11:08 ET150035.45
11:09 ET230735.47
11:11 ET720635.4398
11:13 ET420035.47
11:15 ET210035.49
11:20 ET334435.43
11:22 ET1108535.4678
11:24 ET250035.47
11:26 ET30035.47
11:27 ET334035.54
11:29 ET100935.49
11:31 ET20035.51
11:33 ET290035.71
11:36 ET398535.83
11:38 ET1675636.02
11:40 ET40036.03
11:42 ET70036.13
11:44 ET65336.08
11:45 ET112336.155
11:47 ET150936.21
11:49 ET505036.185
11:51 ET78736.2
11:54 ET40036.25
11:56 ET120036.315
11:58 ET34036.13
12:00 ET20036.115
12:02 ET30036.08
12:03 ET154036.01
12:05 ET100036.1385
12:07 ET641436.29
12:09 ET130036.21
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesVERV
Verve Therapeutics Inc
1.8B
-14.0x
---
United StatesISEE
IVERIC bio Inc
1.6B
-10.9x
---
United StatesCLDX
Celldex Therapeutics Inc
1.7B
-17.7x
---
United StatesDAWN
Day One Biopharmaceuticals Inc
1.7B
-14.4x
---
United StatesPCVX
Vaxcyte Inc
1.6B
-10.0x
---
United StatesZNTL
Zentalis Pharmaceuticals Inc
1.7B
-7.5x
---
As of 2022-08-15

Company Information

Verve Therapeutics, Inc. is a genetic medicines company, developing an approach to the care of cardiovascular disease (CVD) transforming treatment from chronic management to single-course gene editing medicines. The Company’s initial two programs target PCSK9 and ANGPTL3, respectively, genes that regulate levels of blood lipids. Its lead product candidate, VERVE-101, is designed to permanently turn off the PCSK9 gene in the liver. Reduction of PCSK9 protein in the blood improves the ability of the liver to clear LDL-C from the blood. VERVE-101 utilizes LNP-mediated delivery to target the liver and base editing technology to make a single base change at a specific site in the PCSK9 gene in order to disrupt PCSK9 protein production. It is advancing VERVE-101 initially for the treatment of heterozygous familial hypercholesterolemia. Its second program is designed to permanently turn off the ANGPTL3 gene in the liver. ANGPTL3 is a key regulator of cholesterol and triglyceride metabolism.

Contact Information

Headquarters
500 Technology SquareCAMBRIDGE, MA, United States 02139
Phone
978-501-3026
Fax
302-655-5049

Executives

Independent Chairman of the Board
Burt Adelman
President, Chief Operating Officer
Andrew Ashe
Chief Executive Officer, Director
Sekar Kathiresan
Chief Financial Officer
Allison Dorval
Chief Scientific Officer
Andrew Bellinger

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.8B
Revenue (TTM)
$0.00
Shares Outstanding
57.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-2.58
Book Value
$7.37
P/E Ratio
-14.0x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.